David S Goldberg1, Benjamin French2, James D Lewis3, Frank I Scott4, Ronac Mamtani5, Richard Gilroy6, Scott D Halpern7, Peter L Abt8. 1. Division of Gastroenterology, Department of Medicine, University of Pennsylvania, USA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, USA. Electronic address: david.goldberg@uphs.upenn.edu. 2. Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, USA. 3. Division of Gastroenterology, Department of Medicine, University of Pennsylvania, USA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, USA. 4. Division of Gastroenterology, Department of Medicine, University of Pennsylvania, USA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, USA. 5. Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, USA. 6. Division of Gastroenterology, Department of Medicine, University of Kansas Medical Center, Kansas City, KS, USA. 7. Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, USA; Leonard Davis Institute of Health Economics, University of Pennsylvania, USA; Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania, USA. 8. Division of Transplantation, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Abstract
BACKGROUND & AIMS: Despite an allocation system designed to give deceased-donor livers to the sickest patients, many transplantable livers are declined by U.S. transplant centers. It is unknown whether centers vary in their propensities to decline organs for the highest priority patients, and how these decisions directly impact patient outcomes. METHODS: We analyzed Organ Procurement and Transplantation Network (OPTN) data from 5/1/07-6/17/13, and included all adult liver-alone waitlist candidates offered an organ that was ultimately transplanted. We evaluated acceptance rates of liver offers for the highest ranked patients and their subsequent waitlist mortality. RESULTS: Of the 23,740 unique organ offers, 8882 (37.4%) were accepted for the first-ranked patient. Despite adjusting for organ quality and recipient severity of illness, transplant centers within and across geographic regions varied strikingly (p<0.001) in the percentage of organ offers they accepted for the highest priority patients. Among all patients ranked first on waitlists, the adjusted center-specific organ acceptance rates ranged from 15.7% to 58.1%. In multivariable models, there was a 27% increased odds of waitlist mortality for every 5% absolute decrease in a center's adjusted organ offer acceptance rate (adjusted OR: 1.27, 95% CI: 1.20-1.32). However, the absolute difference in median 5-year adjusted graft survival was 4% between livers accepted for the first-ranked patient, compared to those declined and transplanted at a lower position. CONCLUSION: There is marked variability in center practices regarding accepting livers allocated to the highest priority patients. Center-level decisions to decline organs substantially increased patients' odds of dying on the waitlist without a transplant.
BACKGROUND & AIMS: Despite an allocation system designed to give deceased-donor livers to the sickest patients, many transplantable livers are declined by U.S. transplant centers. It is unknown whether centers vary in their propensities to decline organs for the highest priority patients, and how these decisions directly impact patient outcomes. METHODS: We analyzed Organ Procurement and Transplantation Network (OPTN) data from 5/1/07-6/17/13, and included all adult liver-alone waitlist candidates offered an organ that was ultimately transplanted. We evaluated acceptance rates of liver offers for the highest ranked patients and their subsequent waitlist mortality. RESULTS: Of the 23,740 unique organ offers, 8882 (37.4%) were accepted for the first-ranked patient. Despite adjusting for organ quality and recipient severity of illness, transplant centers within and across geographic regions varied strikingly (p<0.001) in the percentage of organ offers they accepted for the highest priority patients. Among all patients ranked first on waitlists, the adjusted center-specific organ acceptance rates ranged from 15.7% to 58.1%. In multivariable models, there was a 27% increased odds of waitlist mortality for every 5% absolute decrease in a center's adjusted organ offer acceptance rate (adjusted OR: 1.27, 95% CI: 1.20-1.32). However, the absolute difference in median 5-year adjusted graft survival was 4% between livers accepted for the first-ranked patient, compared to those declined and transplanted at a lower position. CONCLUSION: There is marked variability in center practices regarding accepting livers allocated to the highest priority patients. Center-level decisions to decline organs substantially increased patients' odds of dying on the waitlist without a transplant.
Authors: S E Gentry; A B Massie; S W Cheek; K L Lentine; E H Chow; C E Wickliffe; N Dzebashvili; P R Salvalaggio; M A Schnitzler; D A Axelrod; D L Segev Journal: Am J Transplant Date: 2013-07-09 Impact factor: 8.086
Authors: A M Allen; W R Kim; H Xiong; J Liu; P G Stock; J R Lake; S Chinnakotla; J J Snyder; A K Israni; B L Kasiske Journal: Am J Transplant Date: 2014-04-14 Impact factor: 8.086
Authors: David S Goldberg; Benjamin French; Kimberly A Forde; Peter W Groeneveld; Therese Bittermann; Lisa Backus; Scott D Halpern; David E Kaplan Journal: JAMA Date: 2014-03-26 Impact factor: 56.272
Authors: Andrew Wey; Joshua Pyke; David P Schladt; Sommer E Gentry; Tim Weaver; Nicholas Salkowski; Bertram L Kasiske; Ajay K Israni; Jon J Snyder Journal: Liver Transpl Date: 2018-04 Impact factor: 5.799
Authors: Douglas R Murken; Allison W Peng; David D Aufhauser; Peter L Abt; David S Goldberg; Matthew H Levine Journal: Liver Transpl Date: 2017-06 Impact factor: 5.799
Authors: Mary G Bowring; Sheng Zhou; Eric K H Chow; Allan B Massie; Dorry L Segev; Sommer E Gentry Journal: Transplantation Date: 2019-10 Impact factor: 4.939
Authors: Christine E Haugen; Tanveen Ishaque; Abel Sapirstein; Alexander Cauneac; Dorry L Segev; Sommer Gentry Journal: Am J Transplant Date: 2019-03-18 Impact factor: 8.086
Authors: Cory R Schaffhausen; Marilyn J Bruin; Sauman Chu; Helen Fu; Warren T McKinney; David Schladt; Jon J Snyder; W Ray Kim; Jack R Lake; Bertram L Kasiske; Ajay K Israni Journal: Liver Transpl Date: 2020-03 Impact factor: 5.799
Authors: Michael S Mulvihill; Hui J Lee; Jeremy Weber; Ashley Y Choi; Morgan L Cox; Babatunde A Yerokun; Muath A Bishawi; Jacob Klapper; Maragatha Kuchibhatla; Matthew G Hartwig Journal: J Heart Lung Transplant Date: 2020-01-21 Impact factor: 10.247